Pulsed corticosteroid treatment in MS patients stabilizes disease activity following natalizumab withdrawal prior to switching to fingolimod

Taylor and Francis Group, International Journal of Neuroscience, p. 1-6

Journal article published in 2016 by M. E. Evangelopoulos

, V. Koutoulidis, E. Andreadou, D. S. Evangelopoulos, C. Kilidireas

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by